Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Yogen Saunthararajah, MD

216.444.6833

Yogen Saunthararajah, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.444.8170
WorkFax:216.636.2498
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Yogen Saunthararajah, MD, is Associate Staff in the Department of Hematologic Oncology and Blood Disorders at Cleveland Clinic, and an Associate Professor.

Dr. Saunthararajah received undergraduate and medical degrees from the University of Wales College of Medicine, and completed medical and surgical internships at University Hospitals of Wales, United Kingdom. Dr. Saunthararajah served as a Captain (Military Medicine) in the Singapore Armed Forces, Singapore.

Professional Highlights

  • Serves on a National Institutes of Health Advisory Board
  • Awarded grants by the National Institutes of Health

Education & Fellowships

Fellowship - National Institute of Health - Cancer Institute
Hematology/Oncology
Bethesda, MD USA
2000
Residency - University of Hawaii Queens Medical Center
Internal Medicine
Honolulu, HI USA
1997
Residency - University of Hawaii Queens Medical Center
Internal Medicine
Honolulu, HI USA
1996
Internship - University of Hawaii Queens Medical Center
Internal Medicine
Honolulu, HI USA
1994
Medical School - University of Wales College of Medicine, Cardiff University
Wales United Kingdom
1990

Specialty Interests

Acute myeloid leukemia, myelodysplastic syndrome, sickle cell disease/anemia, thalassemia, leukemia, benign hematology, myelodysplasia, cancer, leukopenia, aplastic anemia

Awards & Honors

  • Graduated with Distinctions in Medicine and Surgery
  • Received Excellence Awards from the University of Hawaii and University of Illinois at Chicago
  • Grant awards from the National Institutes of Health and U.S. Department of Defense

Additional Training

  • Completed course work for Duke/NIH Master's in Clinical Research

Innovations & Patents

Patents pending for unique approaches to DNA hypomethylation therapy in cancer, sickle cell disease and thalassemia

Memberships

  • American Society of Hematology
  • American Society of Clinical Oncology

Treatment & Services

  • Clinical Trials
  • Experimental Therapeutics
  • Medical Oncology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/4/2014, Dr. Saunthararajah has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English